We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem. RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform...
Sub-study of the pivotal Phase III TIGeR-PaC clinical trial offers important data to potentially assist in optimization of TAMP therapy RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq:...
With $17.2 million in gross proceeds raised since the beginning of 2024, RenovoRx has sufficient funding to advance pivotal Phase III clinical trial and expand development pipeline into...
Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing pivotal Phase III TIGeR-PaC trial through the second interim readout and...
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform...
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.025 | -2.02429149798 | 1.235 | 1.38 | 1.14 | 14077 | 1.22288522 | CS |
4 | -0.12 | -9.02255639098 | 1.33 | 1.56 | 1.1 | 62838 | 1.17904352 | CS |
12 | -0.38 | -23.8993710692 | 1.59 | 1.86 | 1.1 | 39117 | 1.32787464 | CS |
26 | 0.16 | 15.2380952381 | 1.05 | 2.35 | 0.5306 | 68051 | 1.40720734 | CS |
52 | -1.84 | -60.3278688525 | 3.05 | 3.29 | 0.5306 | 188741 | 2.21040483 | CS |
156 | -7.04 | -85.3333333333 | 8.25 | 16.74 | 0.5306 | 464594 | 7.73153702 | CS |
260 | -7.04 | -85.3333333333 | 8.25 | 16.74 | 0.5306 | 464594 | 7.73153702 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions